Olympus Partners Fund VIII collected 3.5 billion dollars, CEO warned about the trade war storm

Olympus Partners is $ 4 billion to invest after completing the donation collection for the latest flagship fund of the second flagship fund. In a statement on Wednesday, the firm said that the eighth pool came 3.5 billion dollarsAccording to a letter to Olympus investors on March 26, LPS jumped to $ 4 billion with the inclusion of expected re -investments. Olympus, VIII. The fund had set a hard border of $ 4 billion, and the fund was allowed to rise from investors.

Olympus had roughly marketing for a year for the eighth pool, which rose 15% more than the previous fund. Olympus Growth Fund VII collected At the end of 2017, $ 3.04 billion.

At the beginning of this month, Luck Olympus fund reported that VIII has collected $ 2.87 billion.

Olympus is also the founder of the president and CEO Rob Morris. The company invests in business services, food services, consumer products, health services, financial services, industrial services and production. Since the launch in 1988, Olympus has collected $ 12 billion. The company also gave investors back to investors $ 6 billion in 2024, including $ 3 billion. Luck reported.

In the letter, Morris, Trump administration, which causes widespread stock market volatility, the tariff -guided policy and a recession. Morris said private capital managers should do their best to avoid the “incoming missiles ın of tariffs. For enterprises with a supply chain, he proposed to diversify to more secure geographies or to follow alternatives exempted to the tariff. “There are many other tactical movements, but there is no perfect plan to avoid the economic storm in which a trade war can fit,” Morris wrote.

The FON VIII started to invest in January and has completed two transactions so far. Olympus in January bought Aceleving, which is an infrastructure products and services provider in the data center market, for 455 million dollars. PE company also collected the generic pharmaceutical manufacturer Pai Pharma 605 million dollars in February. The agreements were “the fastest Olympus bought two investments in the arrival of a fund”.

This story initially took part in Fortune.com